Show simple item record

dc.contributor.authorJiang, L.
dc.contributor.authorKhawaja, H.
dc.contributor.authorTahsin, S.
dc.contributor.authorClarkson, T.A.
dc.contributor.authorMiranti, C.K.
dc.contributor.authorZohar, Y.
dc.date.accessioned2024-08-03T03:55:35Z
dc.date.available2024-08-03T03:55:35Z
dc.date.issued2024-01-23
dc.identifier.citationJiang L, Khawaja H, Tahsin S, Clarkson TA, Miranti CK and Zohar Y (2024), Microfluidic-based human prostate-cancer-on-chip. Front. Bioeng. Biotechnol. 12:1302223. doi: 10.3389/fbioe.2024.1302223
dc.identifier.issn2296-4185
dc.identifier.doi10.3389/fbioe.2024.1302223
dc.identifier.urihttp://hdl.handle.net/10150/673158
dc.description.abstractLack of adequate models significantly hinders advances in prostate cancer treatment, where resistance to androgen-deprivation therapies and bone metastasis remain as major challenges. Current in vitro models fail to faithfully mimic the complex prostate physiology. In vivo animal models can shed light on the oncogenes involved in prostate cancer development and progression; however, the animal prostate gland is fundamentally different from that of human, and the underlying genetic mechanisms are different. To address this problem, we developed the first in vitro microfluidic human Prostate-Cancer-on-Chip (PCoC) model, where human prostate cancer and stromal fibroblast cells were co-cultivated in two channels separated by a porous membrane under culture medium flow. The established microenvironment enables soluble signaling factors secreted by each culture to locally diffuse through the membrane pores affecting the neighboring culture. We particularly explored the conversion of the stromal fibroblasts into cancer-associated fibroblasts (CAFs) due to the interaction between the 2 cell types. Immunofluorescence microscopy revealed that tumor cells induced CAF biomarkers, αSMA and COL1A1, in stromal fibroblasts. The stromal CAF conversion level was observed to increase along the flow direction in response to diffusion agents, consistent with simulations of solute concentration gradients. The tumor cells also downregulated androgen receptor (AR) expression in stromal fibroblasts, while an adequate level of stromal AR expression is maintained in normal prostate homeostasis. We further investigated tumor invasion into the stroma, an early step in the metastatic cascade, in devices featuring a serpentine channel with orthogonal channel segments overlaying a straight channel and separated by an 8 µm-pore membrane. Both tumor cells and stromal CAFs were observed to cross over into their neighboring channel, and the stroma’s role seemed to be proactive in promoting cell invasion. As control, normal epithelial cells neither induced CAF conversion nor promoted cell invasion. In summary, the developed PCoC model allows spatiotemporal analysis of the tumor-stroma dynamic interactions, due to bi-directional signaling and physical contact, recapitulating tissue-level multicellular responses associated with prostate cancer in vivo. Hence, it can serve as an in vitro model to dissect mechanisms in human prostate cancer development and seek advanced therapeutic strategies. Copyright © 2024 Jiang, Khawaja, Tahsin, Clarkson, Miranti and Zohar.
dc.language.isoen
dc.publisherFrontiers Media SA
dc.rights© 2024 Jiang, Khawaja, Tahsin, Clarkson, Miranti and Zohar. This is an open-access article distributed under the terms of the Creative Commons Attribution License.
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectcancer-associated fibroblasts (CAFs)
dc.subjectmicrofluidics
dc.subjectorgan-on-chip
dc.subjectprostate cancer
dc.subjectprostate tumor invasion
dc.subjectstromal fibroblasts
dc.subjecttumor microenvironment
dc.titleMicrofluidic-based human prostate-cancer-on-chip
dc.typeArticle
dc.typetext
dc.contributor.departmentDepartment of Aerospace and Mechanical Engineering, University of Arizona
dc.contributor.departmentCollege of Sciences, University of Arizona
dc.contributor.departmentDepartment of Molecular and Cellular Biology, University of Arizona
dc.contributor.departmentUniversity of Arizona Cancer Center, University of Arizona
dc.identifier.journalFrontiers in Bioengineering and Biotechnology
dc.description.noteOpen access journal
dc.description.collectioninformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.
dc.eprint.versionFinal Published Version
dc.source.journaltitleFrontiers in Bioengineering and Biotechnology
refterms.dateFOA2024-08-03T03:55:35Z


Files in this item

Thumbnail
Name:
fbioe-12-1302223.pdf
Size:
5.100Mb
Format:
PDF
Description:
Final Published Version

This item appears in the following Collection(s)

Show simple item record

© 2024 Jiang, Khawaja, Tahsin, Clarkson, Miranti and Zohar. This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Except where otherwise noted, this item's license is described as © 2024 Jiang, Khawaja, Tahsin, Clarkson, Miranti and Zohar. This is an open-access article distributed under the terms of the Creative Commons Attribution License.